Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: A case-control study

Haematologica

Volumn 92, Issue 9, 2007, Pages 1293-1294

  Dentali, Francesco ^a   Ageno, Walter ^a,d   Romualdi, Erica ^a   Pesavento, Raffaele ^b   Ghirarduzzi, Angelo ^c   Prandoni, Paolo ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Reggio Emilia Hospital   (Italy)

^d OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Deep vein thrombosis; Hyperhomocysteinemia; Metabolic syndrome

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; RISK ASSESSMENT; RISK FACTOR;

AGED; CASE-CONTROL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE; RISK FACTORS; VENOUS THROMBOSIS;

EID: 36348937311     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11352     Document Type: Article

References (10)

1. Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 2005;3:292-9.
2. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16.
3. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W, et al. Strong Heart Study. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study. Diabetes Care 2003;26:861-7.
4. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, et al. Framingham Offspring Study. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001;24:1403-10.
5. Sanchez-Margalet V, Valle M, Ruz FJ, Gascon F, Mateo J, Goberna R. Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. J Nutr Biochem 2002;13:75-79.
6. Ageno W, Prandoni P, Romualdi E, Ghirarduzzi A, Dentali F, Pesavento R, et al. The metabolic syndrome and the risk of venous thrombosis: a case-control study. J Thromb Haemost 2006;4:1914-8.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-96.
8. den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334:759-62.
9. Langman LJ, Ray JG, Evrovski J, Yeo E, Cole DE. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study. Arch Intern Med 2000;160:961-4.
10. Undas A, Brozek J, Szczeklik A. Homocysteine and thrombosis: from basic science to clinical evidence. Thromb Haemost 2005;94:907-15.